BioCentury | Jun 11, 2020
Deals

With $725M Corvidia takeout, Novo gets clinical atherosclerosis asset

...will be required for ziltivekimab to gain approval. Novo Nordisk will also obtain rights to COR-003...
BioCentury | Jan 5, 2019
Finance

Ready to launch

...Elzonris tagraxofusp Blastic plasmacytoid dendritic cell neoplasm Submit MAA 1Q19 Strongbridge Biopharma plc (NASDAQ:SBBP) Recorlev levoketoconazole...
BioCentury | Aug 10, 2018
Clinical News

Strongbridge's Cushing syndrome candidate meets in Phase III

...Strongbridge Biopharma plc (NASDAQ:SBBP) said Recorlev levoketoconazole met the primary and secondary endpoints in the Phase...
...normal following a two-week minimum withdrawal of Recorlev at the end of the maintenance phase. Recorlev...
...data Milestone: Additional Phase III data (1Q19); Phase III data (1Q19) Chris Lieu Recorlev, levoketoconazole (COR-003, COR003, NormoCort) Strongbridge...
BioCentury | Jun 30, 2018
Finance

Eyes on launches

...Cutaneous T cell lymphoma (CTCL) Ph III interim data 2H18 Strongbridge Biopharma plc (NASDAQ:SBBP) Recorlev levoketoconazole...
BioCentury | Apr 6, 2018
Finance

Smid-cap smorgasbord

...SL-401 Blastic plasmacytoid dendritic cell neoplasm Complete rolling BLA 2Q18 Strongbridge Biopharma plc (NASDAQ:SBBP) Recorlev levoketoconazole...
BioCentury | Jan 6, 2018
Finance

Burgeoning bellwethers

...NASDAQ:STML) SL-401 Blastic plasmacytoid dendritic cell neoplasm Submit BLA 1H18 Strongbridge Biopharma plc (NASDAQ:SBBP) Recorlev levoketoconazole...
BioCentury | Oct 6, 2017
Financial News

NewLink, Strongbridge price follow-ons

...announced the offering after market hours. Strongbridge is conducting a Phase III trial of Recorlev levoketoconazole...
...and CYP21A2 . NewLink Genetics Corp. (NASDAQ:NLNK), Ames, Iowa Strongbridge Biopharma plc (NASDAQ:SBBP), Trevose, Pa. Jennie Walters Recorlev NewLink...
BioCentury | Oct 4, 2017
Financial News

NewLink, Strongbridge price follow-ons

...$1.40 (19%) to $6.10 on Wednesday. Strongbridge is conducting a Phase III trial of Recorlev levoketoconazole...
...of cytochrome P450 family 11 subfamily B polypeptide 1 (CYP11B1) , CYP17A1 and CYP21A2 . Jennie Walters indoximod levoketoconazole NLG8189 Recorlev NewLink...
BioCentury | Oct 17, 2015
Financial News

Strongbridge raises $25M in U.S. listing

...Strongbridge expects data in 1H17 from a Phase III study of lead program levoketoconazole ( COR-003...
BioCentury | Oct 31, 2014
Financial News

Cortendo pulls Oslo IPO to mull U.S. listing, raises $11.3M

...lead candidate NormoCort ( COR-003 ). In August, Cortendo began a Phase III trial of NormoCort...
Items per page:
1 - 10 of 12